DIN 02017709 — PLAQUENIL 200 MG
PLAQUENIL is a tablet of Hydroxychloroquine marketed by SANOFI-AVENTIS CANADA INC. The full Hydroxychloroquine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02017709
- Brand name
- PLAQUENIL
- Active ingredient
- Hydroxychloroquine
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- 4-Aminoquinoline (antimalarial / disease-modifying antirheumatic drug)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hydroxychloroquine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02246691 | APO-HYDROXYQUINE | 200 MG | TABLET | APOTEX INC | MARKETED |
| 02519348 | HYDROXYCHLOROQUINE | 200 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02491427 | JAMP HYDROXYCHLOROQUINE SULFATE | 200 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02424991 | MINT-HYDROXYCHLOROQUINE | 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02511886 | NRA-HYDROXYCHLOROQUINE | 200 MG | TABLET | NORA PHARMA INC | MARKETED |